Tweet
<img alt="" height="1" width="1" />
FDA expands approval of Novartis cancer drug
BusinessWeek
The Food and Drug Administration on Thursday said it approved Novartis AG's drug Tasigna as an initial treatment for a type of blood cancer called chronic myeloid leukemia. Tasigna was cleared as a treatment for patients newly diagnosed with the ...
Novartis cancer drug wins wider US approvalReuters
Novartis wins FDA nod for broader Tasigna useFiercePharma
FDA Approves Novartis' Tasigna For Adults In Earlier Cancer StagesWall Street Journal
Drug Store News -International Business Times -RTT News
all 75 news articles »
More...